Month: August 2023

17 August 2023: Hexagon Composites (OSE: HEX.OL), world leader in composite cylinder technology and related systems that enable safe delivery of clean gaseous energy for transportation, industries and homes, reported record high revenues of NOK 1 368 (1 034) million (excluding Hexagon Purus) in the second quarter 2023.  This represents 32% growth compared to the same quarter last year, driven by higher volumes and improved pricing. The EBITDA reached NOK 148 (90) million. On 29 June, the board of directors of Hexagon Composites ASA resolved to distribute 25% of the outstanding shares in Hexagon Purus ASA as a dividend-in-kind to its shareholders and enter into a total return swap for an additional 5% of the shares, effectively reducing ownership in Hexagon Purus to 38.4%. This reduction entailed deconsolidation of Hexagon Purus from Hexagon...

KH Group PlcStock Exchange Release 17 August 2023 at 8:00 am EEST KH Group Plc’s Half-Year Report 1 January–30 June 2023 Change in strategy is progressing as planned, the divestment of Logistikas was completed in June This is the summary of the Half-Year Report for January–June 2023. The full Half-Year Report is attached to this release and is also available on the company’s website at www.khgroup.com. Change of strategy, company name and reporting practices Based on the change in strategy announced on 15 December 2022, Sievi Capital Plc transformed its operations from a private equity investment company into a conglomerate on 4 May 2023 by a decision of the Annual General Meeting. In connection with this, the company’s name was changed to KH Group Plc. The trading code of the share was previously SIEVI and was changed to KHG as a result...

Company announcement – No. 28 / 2023 Zealand Pharma Announces Financial Results for the First Half of 2023 Strong progress across R&D pipeline and significant strengthening of the balance sheetBoehringer Ingelheim to move into Phase 3 trials with GCGR/GLP-1R dual agonist survodutide (BI456906) in obesity following positive Phase 2 data Encouraging weight loss and tolerability data from long-acting amylin analog ZP8396 Regulatory submission of NDA to the US FDA for dasiglucagon in congenital hyperinsulinism and submission of MAA to EMA for dasiglucagon for the treatment of severe hypoglycemia Strengthened balance sheet with DKK 1.5 billion, resulting in a runway to mid-2026Copenhagen, Denmark, August 17, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development...

(Figures in brackets refer to the corresponding period of 2022.EBITDA for the first quarter was negative USD 9.8 million, mainly caused by a lower utilisation rate with three vessels in operation in Brazil for the whole or parts of the quarter, and costs related to new contract preparations on Safe Concordia and Safe Notos. Prosafe observes a significant increase in tender activity and awards for 2024 and beyond with improved earnings, utilisation and increased day rates. Key events Operations, HSSE and backlogQ2 2023 utilisation of 33.1 (Q2 2022: 81.0) per cent, three out of seven vessels operating during the quarter Safe Zephyrus successfully deployed in Brazil from 30 April Safe Concordia on hire in US Gulf of Mexico from 9 August Safe Notos compliance work completed and back in operation from 14 June Good operating performance...

9M 2022/23Interim financial results, 9M 2022/231 October 2022 – 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK grew 4% to 6,108 millionOrganic growth rates by business area: Ostomy Care 8%, Continence Care 9%, Voice and Respiratory Care 9%, Wound and Skin Care 4% (Wound Care 5%), and Interventional Urology 7%. Continued good momentum across regions in Chronic Care. China Ostomy Care posted double-digit growth, reflecting a lower baseline last year and fully normalised hospital access and level of procedural volumes. Strong quarter in Continence Care, with solid contribution from all product categories, including Collecting Devices where backorders have been resolved. Continued solid momentum in Voice and Respiratory Care, driven by both the laryngectomy and tracheostomy businesses. Growth...

VANCOUVER, British Columbia, Aug. 16, 2023 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime”, or the “Company”) (TSX.V: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to report its operating and financial results for the quarter ended June 30, 2023. Prime is focused on the exploration and development of its wholly owned high-grade Los Reyes Gold-Silver Project in Sinaloa State, Mexico (“Los Reyes” or the “Project”). The Company also announces a change to its board of directors: effective August 16, 2023, Mr. Kerry Sparkes is appointed to the board of directors, replacing Mr. Paul Larkin who has stepped down. Mr. Sparkes is a Technical Advisor to Prime, with over 30 years’ experience in mineral exploration as an exploration geologist and mining executive. He was past Vice President Geology for Franco-Nevada Corporation, where he...